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Background. The gut microbiota of malaria vector mosquitoes grows after a blood meal and limits Plasmodium infection. We
previously showed that penicillin and streptomycin in the ingested blood affect bacterial growth and positively impact mosquito
survival and permissiveness to Plasmodium. In this study, we examine the effects of doxycycline, azithromycin, and co-trimoxazole.
All 3 antibiotics are used in mass drug administration programs and have antimicrobial activities against bacteria and various stages
of malaria parasites.
Methods. The effects of blood meal supplementation with antibiotics on the mosquito microbiota, lifespan, and permissiveness
to Plasmodium falciparum were assessed.
Results. Ingestion of any of the 3 antibiotics signiﬁcantly affected the mosquito microbiota. Azithromycin decreased P falcipa-
rum infection load and mosquito lifespan, whereas at high concentrations, doxycycline increased P falciparum infection load.
Co-trimoxazole negatively impacted infection intensity but had no reproducible effect on mosquito lifespan.
Conclusions. Our data suggest that the overall effect of antibiotic treatment on parameters critical for mosquito vectorial capac-
ity is drug speciﬁc. The negative effect of azithromycin on malaria transmission is consistent with current efforts for disease elim-
ination, whereas additional, larger scale investigations are required before conclusions can be drawn about doxycycline.
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Anopheles mosquitoes are vectors of malaria, which causes 200
million disease incidences per year [1]. Mosquitoes become in-
fected after ingesting a blood meal containing Plasmodium ga-
metocytes, the mosquito infectious parasite stages. Parasites
reproduce sexually in the mosquito midgut lumen, and the mo-
tile ookinetes mature into replicative oocysts after they traverse
the midgut epithelium [2].After approximately 1 week of mitotic
divisions, the oocysts rupture and release thousands of sporozo-
ites that infect the salivary glands and, subsequently, can infect
humans. The mosquito midgut stages represent a major bottle-
neck of parasite development in the mosquito and are critical
in disease transmission. The drop in parasite numbers that occurs
before the oocyst development is partly explained by the activity
of the mosquito immune system, largely a complement-like reac-
tion that occurs during the ookinete-to-oocyst transition, as soon
as ookinetes come into contact with the hemolymph [3], but also
by colonization resistance due to the mosquito microbiota,
known to multiply after a blood meal [4–7]. The proliferating
gut bacteria induce the nuclear factor-κB immune-deﬁciency
pathway in the gut epithelium [6, 8] and directly affect parasites
by producing reactive oxygen species [9].
In a recent study, we investigated how a broad-spectrum anti-
biotic cocktail of penicillin-streptomycin present in ingested
human blood at pharmaceutical concentrations affect the mos-
quito microbiota and, indirectly, the mosquito vectorial capacity
[10]. We showed that the antibiotic cocktail reduced the bacterial
growth by 70% after the blood meal and resulted in an increase in
mosquito permissiveness to the parasite, lifespan, and fecundity.
These data suggested that the presence of antibiotics in the blood
meal might increase the risk of malaria transmission, which
would be of particular importance when implementing mass
drug administration programs, as the chance of a mosquito feed-
ing on an antibiotic treated person is increased.
Besides their antibacterial activity, some antibiotics also affect
parasites [11, 12]. In these cases, we hypothesize that the result-
ing impact of an antibiotic treatment on malaria transmission
will depend on the balance between the microbiota-dependent
and parasite-dependent effects. Among these, doxycycline, azi-
thromycin, and co-trimoxazole are known to have a negative
impact on the asexual stages of parasite multiplication in the
blood [11, 12] but not on gametocytemia [13–15]. Considering
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mosquito stages of parasite development, in vitro assays have
shown that azithromycin and doxycycline reduce Plasmodium
falciparum gametocyte differentiation into male gametes and
Plasmodium berghei ookinete formation, respectively [12].
Co-trimoxazole negatively impacts on the intensity of infection
in Anopheles stephensi mosquitoes [15].
In this study, we investigate the effects of doxycycline, azithro-
mycin, and co-trimoxazole on the vectorial capacity of Anopheles
coluzzii mosquitoes (formerly known as Anopheles gambiae M
form) when added to the blood meal. All 3 antibiotics are used
in large-scale administration programs or trials, including World
Health Organization (WHO)-led programs towards the elimina-
tion of neglected tropical diseases using azithromycin [16, 17],
doxycycline-based trials to ﬁght against onchocerciasis and lym-
phatic ﬁlariasis [18, 19], and co-trimoxazole prophylaxis for
human immunodeﬁciency virus (HIV)-infected or HIV-exposed
people [20].
METHODS
Ethics Statement
The protocols for human blood collection and for mosquito
maintenance were approved by the Centre Muraz Institutional
Ethics Committee under the ethical clearance number 003-
2009/cE-cM. Before enrollment, written informed consent
was taken from each human volunteer and/or their legal
guardian.
Mosquito Colony and Maintenance
Most experiments were performed with female mosquitoes
from an A coluzzii Ngousso colony, established from ﬁeld mos-
quitoes collected in Cameroon in 2006, maintained on human
blood, and fed as adults with 5% fructose. Field parasite infec-
tions were performed with an A coluzzii colony established
from ﬁeld mosquitoes collected in Burkina Faso in 2008, main-
tained on rabbit blood, and fed as adults with 5% glucose. Lar-
vae were fed TetraMin ﬁsh food (Tetra). Insectary temperature
was maintained at 28°C (±1°C) with 70%–80% humidity on a
12-hour light/dark cycle.
Human Blood Feeding and Plasmodium Infections
Plasmodium falciparum NF54 gametocytes were cultured in
RPMI medium (GIBCO) including 300 mg. L-1 L-glutamine
supplemented with 50 mg/L hypoxanthine, 25 mM HEPES
plus 10% heat-inactivated human serum without antibiotics.
Two 25-mL cultures were started 17 and 14 days before the in-
fection at 0.5% parasitemia in 6% v/v washed O+ red blood cells
(RBCs). Media was changed daily. Before mosquito infection,
centrifuged RBCs were pooled and supplemented with 20% of
fresh washed RBCs and human serum (2:3 v/v ratio between
RBCs and serum). For experiments carried out from ﬁeld par-
asites, gametocyte carriers were screened among 5- to 14-year-
old school children in Burkina Faso. Vein blood was sampled
into a lithium heparin-coated tube. After centrifugation,
serum was replaced by European AB serum to limit the chance
of transmission-blocking immunity. Mosquitoes were offered a
blood meal from a membrane-feeding device covered with
Paraﬁlm and kept at 37°C. Stock solutions of doxycycline,
co-trimoxazole (trimethoprim-sulfamethoxazole), and azithro-
mycin were prepared from powders (Sigma-Aldrich) in water,
dimethyl sulfoxide (DMSO), and DMSO, respectively, so that
therapeutic concentrations for each antibiotic is reached when
1.2 µL of the stock is added to 1 mL blood: 5 µg/mL for doxy-
cycline, 1 µg/mL for azithromycin, 2.5 µg/mL for trimethoprim,
and 60 µg/mL for sulfamethoxazole. For experiments per-
formed on A gambiae, the co-trimoxazole solution was pre-
pared in water, to reach therapeutic concentrations when
adding 60 µL of the stock to 1 mL blood. These antibiotics do
not require metabolic activation, and they circulate in the blood
until elimination, mostly in an unmetabolized form [21–24].
Control blood was supplemented with the corresponding
amount of solvent. For each Plasmodium infection, at least
100 mosquitoes per condition were offered a blood meal and
nonengorged mosquitoes were removed. All (or at least 50)
mosquitoes that blood fed and survived until the end of the ex-
periment were dissected for oocyst counts using mercuro-
chrome staining.
Microbiota Analysis by Quantitative Polymerase Chain Reaction
Nonengorged mosquitoes were discarded after the blood meal.
Before dissection, mosquitoes were immersed in 70% ethanol
for 5 minutes in order to kill mosquitoes and to ﬁx surface bac-
teria to the cuticle, then rinsed 3 times in sterile phosphate-buff-
ered saline (PBS) to wash out nonattached bacteria, thus
minimizing sample contamination with cuticle bacteria during
dissection. Midguts were removed and frozen immediately on
dry ice in 3 groups of at least 5 mosquitoes per condition and
stored at −20 °C until processing. Midguts were only excluded
from analysis if they burst and a substantial amount of the gut
content was lost. Samples were homogenized in phenol-chloro-
form in a Precellys 24 homogenizer (Bertin) using 0.5 mm-
wide glass beads (Bertin) for 30 seconds at 6800 rpm and deoxy-
ribonucleic acid (DNA) was extracted with phenol-chloroform.
The 16S ribosomal DNA (rDNA) (Figure 1A) or complementary
DNA of the 16S ribosomal ribonucleic acid (rRNA) (Figure 1C)
was used for bacterial quantiﬁcation and is shown as a ratio of the
Anopheles housekeeping gene 40S ribosomal protein S7 (Vector-
Base gene ID AGAP010592), referred to as S7. Primer sequences
are listed in (Supplementary Table 1). Quantitative polymerase
chain reaction (qPCR) was performed on a 7500 Fast Real-
Time thermocycler (Applied Biosystems) using the SYBR Premix
Ex Taq kit (Takara), following the manufacturer’s instructions.
Microbiota Analysis by 454 Pyrosequencing
The microbiota was analyzed in parallel with our previous anal-
ysis of penicillin-streptomycin treatment, so the control results
are the same [10]. Mosquitoes and midguts samples were
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handled as described above for qPCR analysis, with added pre-
caution to reduce environmental contamination: dissecting
slides and forceps were washed with detergent, rinsed with
water and then with ethanol between each sample, and sam-
ple-containing tubes were pretreated with ultraviolet radiation.
For each sample, at least 15 mosquitoes were dissected. To
ensure contamination control, drops of PBS were transferred
with forceps from a dissecting slide into a sampling tube in
10 steps to mimic dissection routine. Deoxyribonucleic acid
extraction conditions are adapted from method 2 of Yuan
et al [25]. Samples were ﬁrst homogenized for 15 seconds at
6800 rpm in a Precellys 24 homogenizer (Bertin) in a lysis buff-
er (20 mM Tris pH 8.0, 2 mM EDTA, 1.2% Triton, 20 mg/mL
lysozyme, 250 U/mL mutanolysin, 20 U/mL lysostaphin [Sigma-
Aldrich]), then incubated for 30 minutes at 37°C, and homoge-
nized again for 15 seconds. Deoxyribonucleic acid was extracted
under sterile conditions using a DNeasy blood and tissue
kit (QIAGEN). The regions V2–V3 of the 16S rDNA were
ampliﬁed with Phusion polymerase ([New England Biolabs] 27
cycles: 5 seconds at 98°C, 20 seconds at 63°C, 20 seconds at
72°C, followed by 5 minutes at 72°C) using the following primers:
16S-0027F (AGAGTTTGATCCTGGCTCAG) and 16S-0533R
(TTACCGCGGCTGCTGGCAC) attached in 5′ to Roche MID
adapters (Supplementary Table 2). After Picogreen (Life Technol-
ogies) quantiﬁcation, a pool of 48 samples (including the 24 sam-
ples reported here), each of 50 ng DNA, was 454-pyrosequenced
in one-half run of a 454 GS FLX sequencer (Roche) by Beckman
Coulter Genomics. The data set was deposited on the European
Nucleotide Archive [26]. Sequencing resulted in 544 038 se-
quences processed with Qiime (version 1.8.0). Of these,
181 967 reads of 477-base pair average length after primer trun-
cation were assigned to the 24 samples (no primer mismatch al-
lowed), and 180 074 of them were identiﬁed as nonchimeric
using usearch61 [27] (see Supplementary Table 2). Operational
taxonomic units (OTUs) were picked using UCLUST software
with a 97% identity threshold [27]. Among contamination con-
trols, 1 replicate produced only 12 reads after ﬁltering; the other
2 were signiﬁcantly different from mosquito midgut samples
(ANOSIM test output P = .024 and P = .004 on weighted and
unweighted Unifrac distances [28], respectively) and were thus
excluded from subsequent analyses. Alpha diversity was moni-
tored using the number of observed species, the Chao1 species
richness estimation [29, 30], the Shannon index, and the phylo-
genetic diversity whole tree index [31] (Supplementary Table 3).
The OTUs were assigned to taxonomy against the Silva refer-
ence dataset (Release 119) [32].
Survival
Age-matched, 2- to 3-day-old mosquitoes were offered a ﬁrst
control or experimental blood meal, and nonengorged mosqui-
toes were discarded. Mosquitoes were then offered the same
type of blood meal twice a week until the death of the last mos-
quito. Between blood meals, mosquitoes were provided with a
cotton pad moistened with distilled water for oviposition.
Unfed mosquitoes were not removed after the second and
later blood meals. Deaths were counted and carcasses were re-
moved on a daily basis. At least 50 mosquitoes per condition
were used for each of 3 independent replicates.
Statistical Analyses
Statistical analyses were performed by generalized linear mixed
models (GLMM) in R (version 2.15.3). Prevalence data were an-
alyzed by analysis of variance (ANOVA) χ2 test on a logistic re-
gression (glmer). Oocyst counts were analyzed by Wald Z-test
on a zero-inﬂated negative binomial regression (glmmADMB).
16S data (qPCR, family proportions from pyrosequencing) were
analyzed by ANOVA χ2 test on a common linear regression
(lmer). Survival data were analyzed using an ANOVA χ2 test
on a mixed effect Cox model (coxme), using replicates as
Figure 1. Doxycycline, azithromycin, and co-trimoxazole affect the mosquito microbiota. 16S quantitative polymerase chain reaction (qPCR) (A) and 454-pyrosequencing (B)
analysis of the bacterial load in dissected midguts during a course of 2 blood meals, the first one being supplemented with doxycycline (Dox), penicillin-streptomycin (PS), or
water as a control (C). (C) 16S qPCR analysis in sugar-fed mosquitoes (SF) or 24 hours after a blood meal using generic (All) or family-specific primers (Entero., Enterobacter-
iaceae; Flavo, Flavobacteriaceae; Aceto., Acetobacteraceae). The blood meal was supplemented with azithromycin (Azi), co-trimoxazole (Cotrim), or dimethyl sulfoxide as a
control (C). Results show average (±standard error of the mean) from 3 independent experiments. *, P < .05, analysis of variance χ2 test on a common linear regression (lmer).
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random effects. Mixed model analyses decompose model effects
into the contribution of a ﬁxed component (the covariates in
question, the treatments in this study) and a random compo-
nent (the experiments in this study). The ﬁxed effect estimates
are the regression coefﬁcients, and the odds ratios are their ex-
ponential value.
Supporting Data
The data set supporting the results of this article is available
in the European Nucleotide Archive repository, under acces-
sion code PRJEB7708 (control) and XX (doxycycline-treated)
(https://www.ebi.ac.uk/ena/data/view/XX).
RESULTS
Effect of Antibiotics on the Microbiota
We investigated the outcome of the presence of antibiotics in the
blood on the mosquito midgut microbiota. We supplemented
human blood with doxycycline at a therapeutic concentration
of 5 µg/mL [33] and offered it to mosquitoes as a blood meal
through standard membrane feeding. Blood supplemented with
water (the solvent of doxycycline) was used as a control. Treating
the blood with doxycycline did not impact the bacterial load of
dissected mosquito midguts 24 hours after the blood meal
(P = .85) (Figure 1A). This could mean that either the concentra-
tion of doxycycline was too low to affect the mosquito microbiota
or that the reduced growth of some bacteria was compensated by
the expansion of others. To address this question, we followed the
composition of the microbiota by 454 pyrosequencing of the 16S
rDNA from dissected midguts (Figure 1B). We observed that the
relative contribution of Flavobacteriaceae signiﬁcantly decreased
(P = .037), corresponding to a marginally signiﬁcant increase in
the proportion of Enterobacteriaceae (P = .058).
Next, we investigated whether this antibiotic treatment had
any persistent consequences on the microbiota after a subsequent
untreated blood meal. Twenty-four hours after the second blood
meal, we observed higher bacterial growth in doxycycline pre-
exposed mosquitoes (P = .023) (Figure 1A). A microbiota compo-
sition analysis showed that this expansion could not be explained
by the growth of 1 bacterial genus alone, which may have been
selected for its resistance to doxycycline (Figure 1B). On the con-
trary, we observed that the species diversity increased in the mid-
gut upon exposure to doxycycline (Supplementary Table 3).
These results were in contrast to the results obtained previously
following blood supplementation with penicillin-streptomycin.
This cocktail reduced bacterial growth after a ﬁrst blood meal, al-
most clearing the Enterobacteriaceae and reducing the species di-
versity, and did not affect the microbiota after a subsequent
nontreated blood meal [10].
We examined the effects of azithromycin or co-trimoxazole by
dissolving them in DMSO and adding them to human blood also
at the therapeutic concentrations of 1 µg/mL for azithromycin
and 2.5 µg/mL trimethoprim and 60 µg/mL sulfamethoxazole
for co-trimoxazole [33, 34]. Blood supplemented with DMSO
was used as a control. We observed that azithromycin and co-tri-
moxazole led to a 30%marginally signiﬁcant reduction (P = .060)
and to a 52% reduction (P = .0085) of the bacterial load 24 hours
after the blood meal, respectively (Figure 1C). Using bacterial
family-speciﬁc qPCR on 16S rRNA, we observed that the reduc-
tion was stronger on Enterobacteriaceae than on Flavobacteria-
ceae (−61%, P = .0049 vs −26%, P = .072 for azithromycin;
−94%, P = .00015 vs −44%, P = .020 for cotrimoxazole), whereas
Acetobacteraceae grew better in the presence of both antibiotics
(+39%, P = .037 for azithromycin; +150%, P = 7.5e-5 for co-tri-
moxazole). The results show that these antibiotics, especially
co-trimoxazole, have similar effects on the mosquito microbiota
as penicillin-streptomycin [10].
Effect of Antibiotics on Plasmodium Infections
In addition to their effect on bacteria, the 3 antibiotics tested in
this study are also known to exert an antiparasitic activity [12,
15]. This suggests that each of these antibiotics may have 2 op-
posing actions on the mosquito vectorial capacity, by clearing
parasites and by reducing bacteria-dependent colonization re-
sistance. We directly investigated the outcome of these antibiot-
ics on mosquito permissiveness to P falciparum (ie, vector
competence) by adding the antibiotics at therapeutic concentra-
tions to an infectious blood meal minutes before offering it to
mosquitoes and monitoring infection at the oocyst stage. We
ﬁrst infected mosquitoes with cultured P falciparum gameto-
cytes and observed that doxycycline had a nonsigniﬁcant effect,
but a positive trend, on the infection intensity (+59% mean oo-
cyst load, P = .34) (Figure 2A and 2C). To investigate whether
doxycycline was able to affect parasites at higher concentrations,
we repeated this experiment by doubling the concentration (10
µg/mL) and observed a signiﬁcant augmentation in parasite in-
fection intensity (+39% mean oocyst load, P = .027) ( Figure 2B
and 2C). The effects on infection prevalence were not signiﬁ-
cant (+5.7%) (Figure 2A and 2B).
We investigated the effect of doxycycline in a setting more re-
ﬂective of ﬁeld conditions, by infecting laboratory-reared mos-
quitoes with blood drawn from P falciparum gametocyte
carriers in Burkina Faso and supplemented with doxycycline
(at 5 µg/mL) or water just before mosquito feeding. The results
revealed a positive but statistically not signiﬁcant effect of doxy-
cycline on the infection prevalence (+7.3%) (Figure 2A and 2D).
In the same analysis with azithromycin, we observed a clear
negative impact on P falciparum infection intensity, whether in-
fecting with cultured gametocytes or with blood from gameto-
cyte carriers (−42% in mean oocyst intensity, P = 5e-7)
(Figure 3A and 3B). No signiﬁcant effect on infection preva-
lence was observed (−8.3%, P = .25). This indicates that the an-
tiparasitic activity of azithromycin has a stronger impact on
parasite infection than the reduction in bacteria-dependent an-
tiparasitic activity.
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We also infected A coluzzii mosquitoes with blood from
gametocyte carriers to monitor the effect of co-trimoxazole.
As observed with azithromycin, co-trimoxazole signiﬁcantly re-
duced the parasite intensity (−27% mean oocyst load, P = .026)
at the oocyst stage (Figure 3C and 3D). However, it increased
the infection prevalence (+18%, P = .039). To explore further
the observed dysjunction between infection prevalence and in-
tensity, we replaced A coluzzii with its sibling A gambiae mos-
quito species, previously known as A gambiae S form. We
observed that not only the intensity but also the prevalence sig-
niﬁcantly decreased upon co-trimoxazole treatment (−12%
prevalence, P = .031; −34% mean oocyst load, P = .00074) (Fig-
ure 3C and 3D). These data conﬁrm the negative effect of
co-trimoxazole on intensity and suggest that the previously ob-
served effect on prevalence was likely not biologically relevant.
To control for potential differences in the microbiota compo-
sition between our laboratory-reared and ﬁeld mosquitoes, 1 ex-
periment for each antibiotic was performed using mosquitoes
that were reared in the laboratory but emerged in water sampled
from a pool containing A coluzzii larvae. It has been previously
shown that the microbiota composition is highly dependent on
the larval breeding site [35]. The results revealed that the effects
of antibiotics on P falciparum infection in mosquitoes raised in
water collected from natural larval habitats were similar to those
performed using conventionally reared mosquitoes (Figures 2A,
3A, and 3C, gray color).
Effect of Antibiotics on the Mosquito Lifespan
Because the parasite extrinsic incubation period spans approx-
imately half of the mosquito lifespan, the latter is a major deter-
minant of the mosquito vectorial capacity. Thus, we analyzed
the effect of antibiotics on the lifespan of A coluzzii. Mosquitoes
that ingested an antibiotic-treated or control blood meals were
offered a similar blood meal twice a week and their survival was
monitored daily. Doxycycline increased the lifespan by 2 days
until day 23 and had no signiﬁcant effect later (P = .030 until
day 23, P = .53 until day 41) (Figure 4A), whereas azithromycin
decreased the lifespan by 1 to 5 days (P = .037) (Figure 4B).
Co-trimoxazole had no consistent effect on mosquito surviv-
al (P = .56) (Figure 4C). Indeed, independent experiments
showed a signiﬁcant increase (P = .03 on the 1st replicate) or de-
crease (P = .02 on the 3rd replicate) in the lifespan of co-trimox-
azole-exposed mosquitoes. Again, this may be explained by a
difference in the initial microbiota that may be or not sensitive
to co-trimoxazole.
DISCUSSION
In this study, we show that treatments with different antibiotics
result in contrasting effects on the microbiota, the vector com-
petence to P falciparum, and the lifespan of mosquitoes.
Azithromycin and co-trimoxazole reduce the load of the mos-
quito microbiota and modify its composition in a similar fash-
ion to what we previously reported for penicillin-streptomycin,
characterized by a decrease in Enterobacteriaceae [10]. Doxycy-
cline shows a different effect by decreasing the proportion of
Flavobacteriaceae and concomitantly increasing the microbiota
species diversity. This increase may be explained by the reduc-
tion in Elizabethkingia, shown in vitro to have broad antimicro-
bial activity, against both Gram-positive and Gram-negative
bacteria [36].
We examined mosquito vectorial capacity and observed
that azithromycin treatment signiﬁcantly decreased infection by
P falciparum and the lifespan of A coluzzii mosquitoes, whereas
Figure 2. Impact of doxycycline (Dox) on mosquito permissiveness to Plasmodium falciparum. (A and B) Forest plots showing the effects of Dox supplementation on the
intensity and prevalence of infection with P falciparum measured as oocyst load on the mosquito midgut. The therapeutic concentration is 1×. Mosquitoes were infected using
laboratory-cultured P falciparum gametocytes (laboratory) or blood from gametocyte carriers (field). Each line shows odds ratio (±confidence interval) of independent replicates,
and diamonds report summaries. Results shown in gray correspond to mosquitoes raised in water sampled from an Anopheles coluzzii-larvae-containing pool. Data were
analyzed by Wald Z-test on a zero-inflated negative binomial regression (glmmADMB). Strip chart showing the oocyst counts in each individual mosquito infected with naturally
infected blood (C) or laboratory-cultured parasites (D). For C and D, data from all experiments shown in A and B were pooled.
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doxycycline had no signiﬁcant effect on these same parameters.
This result suggests that the balance between the antiparasitic ef-
fect and the microbiota-mediated “proparasitic” effect is highly
drug-speciﬁc. Aside from mosquito permissiveness to parasites
and lifespan, malaria transmission success has been modeled to
depend on the biting rate, the number of mosquitoes per human,
the infectivity of parasites to humans, and the time of parasite
development in the mosquito [37]. Further studies deciphering
the effect of antibiotics on these parameters may highlight addi-
tional impacts on the mosquito vectorial capacity.
The therapeutic concentrations considered here corresponded
to the peak concentrations reported in the patient blood during
the course of a treatment [34,38] to assess the maximum possible
effect of these antibiotics on malaria transmission. Blood antibi-
otic concentrations decrease after the end of a treatment. In
particular, azithromycin and doxycycline concentrations de-
crease to approximately 40%–20% of their peak concentrations
soon after the end of the treatment and remain almost constant
for 40 hours and 16 hours thereafter, respectively. The effects of
these antibiotics at such lower concentrations must be further
investigated.
Mass drug administration with azithromycin is currently rec-
ommended by WHO to ﬁght neglected tropical diseases includ-
ing trachoma and yaws, 2 bacterial diseases that cause blindness
and affect the skin and bones, respectively [16, 17]. Trials are
also being performed to analyze the effect of this antibiotic to
ﬁght other infectious diseases in sub-Saharan Africa and have
notably evidenced a reduction in child mortality [39]. Our
data are indicative of a reduction in malaria transmission as a
result of a 42% reduction in mosquito infection intensity and
Figure 3. Impact of azithromycin and co-trimoxazole on mosquito permissiveness to Plasmodium falciparum. Forest plots showing the effects of azithromycin (A) or co-
trimoxazole (C) supplementation on the intensity and prevalence of infection with P falciparum at the oocyst stage. Mosquitoes were infected using laboratory-cultured P
falciparum gametocytes (laboratory) or blood from gametocyte carriers (field). Each line shows odds ratio (±confidence interval) from an independent replicate, and diamonds
report summaries. Results shown in gray correspond to mosquitoes raised in water sampled from an Anopheles coluzzii-larvae-containing pool. Co-trimoxazole experiments
were performed using A coluzzii and Anopheles gambiae, whereas all azithromycin experiments were performed using A coluzzii. Data were analyzed by Wald Z-test on a zero-
inflated negative binomial regression (glmmADMB). Strip chart showing the oocyst counts in each individual mosquito upon azithromycin (B) or cotrimoxazole (D) treatment. For
C and D, data from all experiments shown in A and B were pooled.
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a nonsigniﬁcant 8% reduction in infection prevalence. These
data ﬁt nicely with a previously published model on transmis-
sion-blocking efﬁcacy, given the mean infection intensity of 24
oocysts/mosquito observed in our experiments [40]. At infec-
tion intensities of 1–5 oocysts/mosquito that are observed in
the ﬁeld [41], this model can predict an effect on prevalence be-
tween 15% and 30% [40]. Such an effect may have a substantial
impact on malaria transmission during azithromycin large-
scale distribution programs, which commonly cover 90% of
the population [42].Therefore, our data suggest that a reduction
in malaria transmission may contribute to the observed general
reduction in infectious diseases upon large-scale treatment with
azithromycin [39].
Our results of the impact of doxycycline exposure on the
mosquito lifespan and permissiveness to P falciparum are non-
signiﬁcant, suggesting that one-off treatments may not affect
malaria epidemiology. Nonetheless, the observed positive
trend in both parameters suggests that mass drug administra-
tion of doxycycline, suggested to ﬁght lymphatic ﬁlariasis and
onchocerciasis [18, 19], may beneﬁt from testing its impact on
malaria transmission at a larger scale. Both diseases are also vec-
tor borne, and microbiota are thought to interfere with nema-
tode infection [7, 43], so this antibiotic may also affect the
transmission of these diseases.
A high proportion of Enterobacteriaceae in the microbiota
has been previously shown to correlate with successful P falcip-
arum infections in Anopheles [44]. In that case, the microbiota
analysis was performed 8 days after P falciparum infection, so it
is unclear whether a higher contribution of Enterobacteriaceae
supports P falciparum infection or whether the parasite
promotes Enterobacteriaceae. In this study, we observed that
doxycycline treatment increases the proportion of Enterobacter-
iaceae in uninfected mosquitoes and tends to increase the per-
missiveness to P falciparum. Together, these studies suggest that
a higher proportion in Enterobacteriaceae promotes the devel-
opment of P falciparum in the mosquito gut. However, such
correlations at the family level must be considered with care, be-
cause the effect of bacteria on Plasmodium is at least partially
strain-speciﬁc [9, 45].
Finally, the results on co-trimoxazole, with high variations be-
tween experiments, highlight the conﬂicting effects of the anti-
bacterial and antiparasitic activities of this antibiotic. This may
be linked to the fact that co-trimoxazole has a strong effect on
the mosquito microbiota. The positive effect on prevalence versus
negative impact on intensity of A coluzzii infections suggests that
a positive impact due to the effect on the microbiota only hap-
pens in certain mosquitoes, depending on the microbiota com-
position, whereas a negative direct effect inhibits all the parasites.
CONCLUSIONS
Taken together, our results indicate that doxycycline, azithro-
mycin, and co-trimoxazole have diverse actions on the midgut
microbiota, the permissiveness to malaria parasites, and the life-
span of malaria vector mosquitoes. The clearest effect is seen
with azithromycin, which, despite reducing the bacterial load
in the mosquito midgut, has a negative impact on its permis-
siveness to malaria infection. Because it also negatively affects
the mosquito lifespan, azithromycin treatment may reduce ma-
laria transmission.
Supplementary Data
Supplementary material is available online at Open Forum Infectious
Diseases online (http://OpenForumInfectiousDiseases.oxfordjournals.org/).
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